P704 Do antiglycan antibodies have an impact on the course of Crohn's disease?
- Authors:
- S Kaymakoglu, A Ormeci, O Mutluay Soyer, B Baran, S Gokturk, S Evirgen, ...
- Journal:
- Journal of Crohn's and Colitis 7 (Supplement_1), S293-S293
- Publication Year:
- 2013
- Citations:
- 0
- Subject Area:
- İnflamatuar Bağırsak Hastalıkları
Other Publications in This Subject Area
- Cyclosporine therapy as a rescue treatment in steroid refractory acute severe ulcerative colitis: a real life data from a tertiary center (2022)
- Inflammatory bowel disease and mycobacteria: how much can we trust isoniazid prophylaxis during antitumor necrosis factor therapy? (2019)
- Belching in irritable bowel syndrome: an impedance study (2017)
- Does the number of mucosal immune cells differ in irritable bowel syndrome and its subtypes? (2017)
- Steroid-refractory inflammatory bowel disease is a risk factor for CMV infection. (2016)
This list was extracted from Prof. Dr. Çetin Karaca's public Google Scholar profile; DOI matches were verified against CrossRef. Citation counts reflect Google Scholar's data at extraction time and are not updated in real time.
← Back to İnflamatuar Bağırsak Hastalıkları publications